首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1729266

日本生物標記市場報告（按產品、類型、疾病、應用、最終用戶和地區）2025-2033

Japan Biomarkers Market Report by Product, Type, Disease, Application, End User, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年，日本生物標記市場規模達到 40 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 118 億美元，2025-2033 年期間的成長率 (CAGR) 為 11.7%。市場受到多種重要因素的推動，包括慢性病發病率的上升、生物技術和基因組學的不斷進步、個性化醫療的趨勢、分析技術的不斷改進以及醫療保健專業人員和患者對生物標記優勢的認知不斷提高。

生物標記是源自人體內可量化的訊號，可為了解各種生物功能和狀態提供重要見解。這些指標可以涵蓋多種物質，從蛋白質、基因、荷爾蒙到身體特徵。生物標記在醫學研究、診斷和治療計劃領域發揮關鍵作用。它們使醫療保健專業人員和研究人員能夠評估疾病的存在或進展，評估治療介入的有效性，並預測個人對特定健康狀況的傾向。在市場研究和諮詢服務中，全面掌握生物標記是必不可少的，因為它們可以為醫療保健和製藥領域的決策過程提供資訊。這種理解對於創新解決方案和策略方法的發展起著根本性的作用。

日本生物標記市場趨勢：

在日本生物標記市場中，癌症、心血管疾病和糖尿病等慢性疾病的激增成為關鍵的成長動力。生物標記對於這些疾病的早期發現、持續監測和發展個人化治療方法至關重要。日本在生物技術和基因組學領域的不斷進步有助於識別新的生物標記物，擴大其在診斷、藥物開發和精準醫療等領域的效用。在日本市場的藥物研究中，生物標記在輔助識別目標、評估候選藥物的功效和進行安全性分析方面發揮著不可或缺的作用。這加快了藥物開發過程，減少了費用，並提高了治療介入的整體成功率。日本採用的個人化醫療實踐依賴生物標記，根據患者的不同情況量身定做治療方案，從而增強治療效果，同時最大限度地減少不良影響。與全球許多其他地區一樣，日本的人口老化極大地推動了市場的成長，因為老年人對慢性疾病的易感性更高，這凸顯了利用生物標記進行早期發現和有效疾病管理的必要性。此外，日本在基因組學、蛋白質組學和成像等分析技術方面的不斷進步，提高了生物標記檢測的精確度和特異性，進一步拓寬了其應用範圍，促進了日本市場的擴張。

日本生物標記市場細分：

產品洞察：

耗材
服務
軟體

類型洞察：

療效生物標記
安全生物標記
驗證生物標記

疾病見解：

癌症
心血管疾病
神經系統疾病
免疫系統疾病
腎臟疾病
其他

應用程式洞察：

診斷
藥物研發
個人化醫療
其他

最終用戶洞察：

製藥和生物技術公司
診斷與研究實驗室
醫院和專科診所
其他

競爭格局：

市場研究報告也對市場競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本生物標記市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本生物標記市場有何影響？
日本生物標誌市場依產品分類是怎樣的？
日本生物標記市場依類型分為哪些類型？
日本生物標記市場根據疾病的分類是怎樣的？
日本生物標誌市場根據應用如何分類？
根據最終用戶，日本生物標記市場是如何分類的？
日本生物標誌市場的價值鏈分為哪些階段？
日本生物標記的主要促進因素和挑戰是什麼？
日本生物標誌市場的結構是怎麼樣的？主要參與者是誰？
日本生物標誌市場的競爭程度如何？

本報告回答的關鍵問題：

日本生物標記市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本生物標記市場有何影響？
日本生物標誌市場依產品分類是怎樣的？
日本生物標記市場依類型分為哪些類型？
日本生物標記市場根據疾病的分類是怎樣的？
日本生物標誌市場根據應用如何分類？
根據最終用戶，日本生物標記市場是如何分類的？
日本生物標誌市場的價值鏈分為哪些階段？
日本生物標記的主要促進因素和挑戰是什麼？
日本生物標誌市場的結構是怎麼樣的？主要參與者是誰？
日本生物標誌市場的競爭程度如何？

Japan biomarkers market size reached USD 4.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.8 Billion by 2033, exhibiting a growth rate (CAGR) of 11.7% during 2025-2033. The market is being driven by several significant factors, including the increasing incidence of chronic illnesses, ongoing progress in biotechnology and genomics, the trend toward personalized medicine, continuous improvements in analytical technologies, and growing awareness among healthcare professionals and patients regarding the advantages of biomarkers.

Biomarkers are quantifiable signals originating from within the human body that offer vital insights into various biological functions and states. These indicators can encompass a diverse array of substances, ranging from proteins, genes, and hormones to physical attributes. Biomarkers hold a pivotal role in the domains of medical research, diagnosis, and treatment planning. They empower healthcare professionals and researchers to evaluate the presence or progression of diseases, assess the efficacy of therapeutic interventions, and anticipate an individual's predisposition to specific health conditions. In the context of market research and consulting services, a comprehensive grasp of biomarkers is indispensable as they inform decision-making processes within the healthcare and pharmaceutical sectors. This understanding plays a fundamental role in the development of innovative solutions and strategic approaches.

Japan Biomarkers Market Trends:

In the context of the Japan biomarkers market, the surge in chronic illnesses, encompassing conditions like cancer, cardiovascular disorders, and diabetes, stands as a pivotal growth driver. Biomarkers are instrumental in the early detection, ongoing monitoring, and formulation of individualized treatment approaches for these diseases. Japan's continuous strides in biotechnology and genomics contribute to the identification of novel biomarkers, extending their utility in areas such as diagnostics, drug development, and precision medicine. In pharmaceutical research within the Japanese market, biomarkers play an integral role by aiding in target identification, evaluating the efficacy of drug candidates, and conducting safety profiling. This expedites the drug development process, curtails expenses, and enhances the overall success rates of therapeutic interventions. The adoption of personalized medicine practices in Japan is reliant on biomarkers to customize treatment regimens according to the distinct profiles of patients, thereby augmenting treatment outcomes while minimizing adverse effects. Japan's aging population, like many other regions globally, significantly propels market growth, given the heightened susceptibility of elderly individuals to chronic ailments, underscoring the need for early detection and effective disease management facilitated by biomarkers. Furthermore, Japan's continuous enhancements in analytical technologies, encompassing genomics, proteomics, and imaging, enhance the precision and specificity of biomarker detection, further broadening their applications and fostering market expansion within the country.

Japan Biomarkers Market Segmentation:

Product Insights:

Consumables
Services
Software

Type Insights:

Efficacy Biomarkers
Safety Biomarkers
Validation Biomarkers

Disease Insights:

Cancer
Cardiovascular Disorders
Neurological Disorders
Immunological Disorders
Renal Disorders
Others

Application Insights:

Diagnostics
Drug Discovery and Development
Personalized Medicine
Others

End User Insights:

Pharmaceutical and Biotechnology Companies
Diagnostic and Research Laboratories
Hospitals and Specialty Clinics
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan biomarkers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan biomarkers market?
What is the breakup of the Japan biomarkers market on the basis of product?
What is the breakup of the Japan biomarkers market on the basis of type?
What is the breakup of the Japan biomarkers market on the basis of disease?
What is the breakup of the Japan biomarkers market on the basis of application?
What is the breakup of the Japan biomarkers market on the basis of end user?
What are the various stages in the value chain of the Japan biomarkers market?
What are the key driving factors and challenges in the Japan biomarkers?
What is the structure of the Japan biomarkers market and who are the key players?
What is the degree of competition in the Japan biomarkers market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biomarkers Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Biomarkers Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Biomarkers Market - Breakup by Product

6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Services
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Software
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)

7 Japan Biomarkers Market - Breakup by Type

7.1 Efficacy Biomarkers
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Safety Biomarkers
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Validation Biomarkers
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)

8 Japan Biomarkers Market - Breakup by Disease

8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Cardiovascular Disorders
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Neurological Disorders
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Immunological Disorders
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Renal Disorders
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2019-2024)
- 8.6.2 Market Forecast (2025-2033)

9 Japan Biomarkers Market - Breakup by Application

9.1 Diagnostics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Drug Discovery and Development
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Personalized Medicine
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Others
- 9.4.1 Historical and Current Market Trends (2019-2024)
- 9.4.2 Market Forecast (2025-2033)

10 Japan Biomarkers Market - Breakup by End User

10.1 Pharmaceutical and Biotechnology Companies
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Diagnostic and Research Laboratories
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Hospitals and Specialty Clinics
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
10.4 Others
- 10.4.1 Historical and Current Market Trends (2019-2024)
- 10.4.2 Market Forecast (2025-2033)

11 Japan Biomarkers Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Biomarkers Market - Industry Analysis

13.1 Drivers, Restraints and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis